By Sheri R. Colberg, PhD, FACSM

How active are you? Unless you’re exercising more than several hours a day already, you probably have room to add more in for additional health benefits. Exercise is about the best medicine that there is for so many health conditions, including diabetes. Being active helps manage emotional stress and stave off depression—far better than antidepressant medications and with no bad side effects. It naturally bestows your body with antioxidant effect, making you less likely to develop most types of cancer—or even the common cold.

How much higher is the rate of cardiovascular (CV) death among unmarried vs married patients who are at high CV risk, according to a recent study? A. 19% B. 28% C. 34% D. 45% E. 56% Follow the link for the answer.

For a patient with type 2 who has an A1c of 8% and is on metformin, has tried diet change and exercise, and is 25 pounds overweight, which of the following would you prefer: GLP-1, SGLT-2, or something else? Follow the link to share your opinion.

Genome-wide association study identified novel signal near GABRR1, which was not seen in Asians

Younger age at menarche linked to increased risk of diabetes in women with a BMI of ≥25 kg/m²

The 66th Annual Clinical Meeting of the American College of Obstetricians and GynecologistsThe annual meeting of the American College of Obstetricians and Gynecologists was held from April 27 to 30 in Austin, Texas, and attracted more than 3,000 participants from around the world, including clinicians, academicians, allied health professionals, and …

When I was doing Diabetes CME for clinicians and pharmacists I had a couple of slides that showed a patient hooked up to a machine as big as a small car. This device was able to control glucose levels way back in the 70’s. The question we used to ask …

Man, 52 years of age, with obesity and type 2 diabetes, was switched from daily liraglutide (Victoza) 1.8mg to weekly semaglutide (Ozempic) 0.25mg. I was very clear with patient about the switch being from a daily injection to a weekly and that we would be increasing the semaglutide weekly.

In this week's Homerun Slides, a closer look at the Systolic Blood Pressure Intervention Trial (SPRINT).

The foregoing observations have detailed the best established risk factors associated with insulin resistance as well some novel emerging risk factors as additionally detailed in Table 23.2, including nutritional measures such as Vitamin D. These are not comprehensive but rather a selection of emerging pathways of interest. Clearly, future research should increasingly harness genetics as well as observational data to better determine causal risk pathways. Similarly, further data are needed to better determine the extent to which insulin resistance is, or is not, linked to cardiovascular risk.